Jean Jacques Bienaime - 07 Feb 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
07 Feb 2023
Net transactions value
-$882,540
Form type
4
Filing time
14 Feb 2023, 19:00:56 UTC
Previous filing
18 Jan 2023
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Gift $0 -200 -0.08% $0.000000 247,333 07 Feb 2023 Shares held by Jean-Jacques Bienaime Family Trust F2
transaction BMRN Common Stock Gift $0 +100 $0.000000 100 07 Feb 2023 Shares held as UTMA custodian for child F2
transaction BMRN Common Stock Gift $0 +100 $0.000000 100 07 Feb 2023 Shares held as UTMA custodian for child F2
transaction BMRN Common Stock Options Exercise $1,017,150 +15,000 +4.7% $67.81 335,324 10 Feb 2023 Direct F3
transaction BMRN Common Stock Sale $1,651,650 -15,000 -4.5% $110.11 320,324 10 Feb 2023 Direct F3
transaction BMRN Common Stock Options Exercise $406,860 +6,000 +1.9% $67.81 326,324 13 Feb 2023 Direct F3
transaction BMRN Common Stock Sale $654,900 -6,000 -1.8% $109.15 320,324 13 Feb 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15,000 -7.8% $0.000000 178,130 10 Feb 2023 Common Stock 15,000 $67.81 Direct F1, F3
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6,000 -3.4% $0.000000 172,130 10 Feb 2023 Common Stock 6,000 $67.81 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.
F2 This transaction involved a gift of securities by the reporting person to his child under the Uniform Transfers to Minors Act.
F3 Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.